Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 6Spondylitis, Ankylosing 2Psoriasis 2Crohn Disease 2Colitis, Ulcerative 2Uveal Melanoma 1Plaque Psoriasis 1Melanoma 1Hidradenitis Suppurativa 1Healthy Adult Male 1Healthy 1Acne Vulgaris 1Abscess 1

Interventions

pimodivir 1Rosuvastatin Calcium 1Cyclosporine 1Adalimumab 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Healthy × Adalimumab × Clear all
NCT02912247 2019-03-07

Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Completed
183 enrolled

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡